LGBTQ+ Inclusive
Cancer Screening
Guidelines

Discussion
The current standard practice of collecting
a patient's medical history ascertains some cancer
risk factors, such as surgical history, family history,
medications, and substance use, but lacks other key
factors including a comprehensive organ inventory.
In order to appropriately screen individuals for
cervical, breast, and prostate cancer, it is necessary
to know both what organs are currently present
and what organs were present at birth. The
importance of an organ inventory not only ensures
thorough screening, but also limits physician bias
in decision making, increases patient
comfortability, and normalizes providing
healthcare to patients of all gender identities. The
ScreenALL algorithm stratifies a patient’s cancer
risk utilizing self-reported information on organ
history, surgical history, and medical therapy,
eliminating bias and confusion caused by genderbased screening and allowing for universal use.
Future direction for this algorithm includes the
addition of guidelines for repeat screening after
someone has had a positive screen, as well as the
inclusion of appropriate physical exam maneuvers
to be done at annual wellness visits based on the
organs a patient currently has. Additionally, the
ScreenALL algorithm should be compared
alongside standard screening practices to
determine if it results in more accurate
identification of appropriate cancer screenings and
an increase in rates of screening overall.

Jacob Nair, Stephanie Perez
SKMC Class of 2023

Background

Proposed Intervention

According to the National Health Interview Survey,
individuals who self-identify as LGTBQ+ are 50%
more likely to be diagnosed with cancer compared
to cisgender, heterosexual individuals1. This is
partially due to the lower rates of cancer screening
in transgender patients3. Contributing factors to
this disparity include lack of official cancer
screening recommendations for LGBTQ+ patients,
physician bias, patient distrust, and physician
uncertainty regarding how to appropriate screen
LGBTQ+ patients2. Current cancer screening
practices use gender as the foundation for their
screening recommendations, which overlooks
patients with congenital anomalies, prior surgeries,
or medical therapies that contribute to cancer risk.
An inclusive algorithm is necessary to ensure that
all patients are appropriately screened for cancer,
which should increase screening rates and
subsequently lower rates of cancer diagnosis in the
LGBTQ+ community.

Conclusions and Implications
The current gender-based approach to cancer
screening is not inclusive of individuals whose
organs may differ from what is traditionally
assumed based on their gender. As the landscape of
society continues to evolve, we must change our
methods of screening individuals from a binary
approach to one that can be used to screen everyone,
regardless of sex and gender identity. The
ScreenALL algorithm focuses on utilizing a selfreported organ inventory as the starting point for
cancer screening recommendations. This approach
should help to decrease physician uncertainty and
bias when screening patient who exist outside the
binary, ultimately increasing the number of
LGBTQ+ individuals who are screened for cancer
and reducing disparity in rates of cancer diagnosis as
compared to cisgender, heterosexual individuals.

Aims
1. Development of an organ-based screening tool
to collect health information that is pertinent to
cancer risk
2. Creation of an inclusive cancer screening
algorithm that is tailored to patients based on
their individual risk factors

Methods
The proposed intervention to address this
disparity is the development of an algorithm that
utilizes a patient's individual risk factors to
determine which cancers they should be screened
for, and at what interval. Patients will fill out a
corresponding survey upon check-in to their
appointments, which will include selfidentification of organs, family history, and
personal risk factors. Upon completion, the
patient’s information will be uploaded into the
EMR, and the algorithm will identify the cancer
screenings for which they qualify.
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